Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10823 | 964 | 31.3 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
233 | 19645 | BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DEFIBROTIDE | Author keyword | 121 | 75% | 9% | 86 |
2 | VENO OCCLUSIVE DISEASE | Author keyword | 109 | 59% | 13% | 121 |
3 | HEPATIC VENO OCCLUSIVE DISEASE | Author keyword | 20 | 53% | 3% | 26 |
4 | SINUSOIDAL OBSTRUCTION SYNDROME | Author keyword | 19 | 46% | 3% | 31 |
5 | VENOOCCLUSIVE DISEASE | Author keyword | 17 | 48% | 3% | 26 |
6 | VENO OCCLUSIVE DISEASE OF THE LIVER | Author keyword | 12 | 86% | 1% | 6 |
7 | HEPATIC SINUSOIDAL OBSTRUCTION SYNDROME | Author keyword | 8 | 75% | 1% | 6 |
8 | HEPATIC VOD | Author keyword | 7 | 67% | 1% | 6 |
9 | HEPATIC VENOOCCLUSIVE DISEASE | Author keyword | 6 | 58% | 1% | 7 |
10 | VENOUS OCCLUSIVE DISEASE | Author keyword | 4 | 56% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VENOCCLUSIVE DISEASE | 161 | 92% | 7% | 65 |
2 | DEFIBROTIDE | 52 | 59% | 6% | 58 |
3 | HEPATIC VENOOCCLUSIVE DISEASE | 51 | 30% | 15% | 143 |
4 | ANTI THROMBOTIC ACTIVITY | 37 | 100% | 1% | 14 |
5 | VENOOCCLUSIVE DISEASE | 33 | 20% | 16% | 153 |
6 | SIGNIFICANT TOXICITY | 32 | 70% | 3% | 26 |
7 | PROSTACYCLIN ENHANCING AGENT | 23 | 100% | 1% | 10 |
8 | VENO OCCLUSIVE DISEASE | 21 | 22% | 9% | 82 |
9 | SEVERE VENOOCCLUSIVE DISEASE | 16 | 54% | 2% | 20 |
10 | ANTITHROMBOTIC SUBSTANCE | 15 | 88% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation | 2015 | 1 | 74 | 88% |
THE SYNDROME OF HEPATIC VENOOCCLUSIVE DISEASE AFTER MARROW TRANSPLANTATION | 1995 | 285 | 88 | 58% |
Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease) | 2002 | 224 | 139 | 72% |
Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies | 2008 | 47 | 86 | 79% |
Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome | 2010 | 50 | 120 | 56% |
Drug safety evaluation of defibrotide | 2013 | 5 | 77 | 78% |
Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome | 2006 | 40 | 148 | 78% |
The role of the endothelium in the short-term complications of hematopoietic SCT | 2011 | 21 | 40 | 53% |
Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation | 2003 | 64 | 101 | 84% |
Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations | 2010 | 21 | 75 | 73% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HEMATOL ONCOL ADULT ONCOL | 3 | 100% | 0.3% | 3 |
2 | SPANISH BONE MARROW DONOR PROGRAM | 3 | 100% | 0.3% | 3 |
3 | GASTROENTEROL HEPATOL SECT D2 190 | 2 | 33% | 0.4% | 4 |
4 | GASTROENTEROL HEPATOL SECT D2190 | 1 | 50% | 0.2% | 2 |
5 | STEM CELL TRANSPLANTAT UNITHEMATOL | 1 | 100% | 0.2% | 2 |
6 | ABT HAEMATOL INTERNIST ONKOL | 1 | 33% | 0.3% | 3 |
7 | EUGENE PLEBAUM PHARM ALLIED HLTH PROFESS | 1 | 33% | 0.3% | 3 |
8 | BONE MARROW TRANSPLANTAT UNIT HEMATOL | 1 | 40% | 0.2% | 2 |
9 | ABC CHILD HLTH | 1 | 50% | 0.1% | 1 |
10 | BONE MARROW TRANSPLANTAT PROGRAM ATLANTIC CANADA | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000223423 | BUSULFAN//TREOSULFAN//INTRAVENOUS BUSULFAN |
2 | 0.0000153515 | RADIATION NEPHROPATHY//SCHISTOCYTE//RADIATION NEPHRITIS |
3 | 0.0000093987 | PELIOSIS HEPATIS//PELIOSIS//PELIOTIC CHANGE |
4 | 0.0000086398 | IDIOPATHIC PORTAL HYPERTENSION//NODULAR REGENERATIVE HYPERPLASIA//HEPATOPORTAL SCLEROSIS |
5 | 0.0000078186 | HBV REACTIVATION//HEPATITIS B VIRUS REACTIVATION//HEPATITIS B REACTIVATION |
6 | 0.0000072306 | BUDD CHIARI SYNDROME//HEPATIC VEIN THROMBOSIS//HEPATIC VEINS THROMBOSIS |
7 | 0.0000067312 | IDIOPATHIC PNEUMONIA SYNDROME//BRONCHIOLITIS OBLITERANS//LATE ONSET NONINFECTIOUS PULMONARY COMPLICATIONS |
8 | 0.0000066495 | GRAFT VERSUS HOST DISEASE//CHRONIC GRAFT VERSUS HOST DISEASE//GVHD |
9 | 0.0000053559 | RADIATION INDUCED LIVER DISEASE//RADIATION INDUCED LIVER INJURY//YONSEI LIVER CANC CLIN |
10 | 0.0000046066 | GENITAL GVHD//CARDIAC LATE EFFECTS//HCT HEMATOPOIETIC CELL TRANSPLANTATION |